Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies

作者: Giuseppa Pistritto , Daniela Trisciuoglio , Claudia Ceci , Alessia Garufi , Gabriella D'Orazi

DOI: 10.18632/AGING.100934

关键词:

摘要: Apoptosis is a form of programmed cell death that results in the orderly and efficient removal damaged cells, such as those resulting from DNA damage or during development. can be triggered by signals within cell, genotoxic stress, extrinsic signals, binding ligands to surface receptors. Deregulation apoptotic machinery an hallmark cancer. alteration responsible not only for tumor development progression but also resistance therapies. Most anticancer drugs currently used clinical oncology exploit intact signaling pathways trigger cancer death. Thus, defects may result drug so limiting efficacy Therefore, better understanding improve therapy bypass resistance. This review will highlight role fundamental regulators apoptosis how their deregulation, including activation anti-apoptotic factors (i.e., Bcl-2, Bcl-xL, etc) inactivation pro-apoptotic p53 pathway) ends up In addition, therapeutic strategies aimed at modulating activity are briefly discussed.

参考文章(176)
AJ Minn, CM Rudin, LH Boise, CB Thompson, Expression of Bcl-xL Can Confer a Multidrug Resistance Phenotype Blood. ,vol. 86, pp. 1903- 1910 ,(1995) , 10.1182/BLOOD.V86.5.1903.BLOODJOURNAL8651903
Karen H Vousden, p53: death star. Cell. ,vol. 103, pp. 691- 694 ,(2000) , 10.1016/S0092-8674(00)00171-9
Michael O Hengartner, Apoptosis: corralling the corpses. Cell. ,vol. 104, pp. 325- 328 ,(2001) , 10.1016/S0092-8674(01)00219-7
Gustavo P. Amarante-Mendes, Thomas S. Griffith, Therapeutic applications of TRAIL receptor agonists in cancer and beyond. Pharmacology & Therapeutics. ,vol. 155, pp. 117- 131 ,(2015) , 10.1016/J.PHARMTHERA.2015.09.001
Guy S. Salvesen, Colin S. Duckett, IAP proteins: blocking the road to death's door Nature Reviews Molecular Cell Biology. ,vol. 3, pp. 401- 410 ,(2002) , 10.1038/NRM830
Tal Teitz, Tie Wei, Marcus B. Valentine, Elio F. Vanin, Jose Grenet, Virginia A. Valentine, Frederick G. Behm, A. Thomas Look, Jill M. Lahti, Vincent J. Kidd, Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN Nature Medicine. ,vol. 6, pp. 529- 535 ,(2000) , 10.1038/75007
Mark Wade, Luo Wei Rodewald, Joaquín M. Espinosa, Geoffrey M. Wahl, BH3 activation blocks Hdmx suppression of apoptosis and co-operates with Nutlin to induce cell death Clinical Cancer Research. ,vol. 14, ,(2008)
M. Cristina Moroni, Emma S. Hickman, Eros Lazzerini Denchi, Greta Caprara, Elena Colli, Francesco Cecconi, Heiko Müller, Kristian Helin, Apaf-1 is a transcriptional target for E2F and p53 Nature Cell Biology. ,vol. 3, pp. 552- 558 ,(2001) , 10.1038/35078527
María S Soengas, Paola Capodieci, David Polsky, Jaume Mora, Manel Esteller, Ximena Opitz-Araya, Richard McCombie, James G Herman, William L Gerald, Yuri A Lazebnik, Carlos Cordón-Cardó, Scott W Lowe, None, Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. ,vol. 409, pp. 207- 211 ,(2001) , 10.1038/35051606
F Mancini, L Pieroni, V Monteleone, R Lucà, L Fici, E Luca, A Urbani, S Xiong, S Soddu, R Masetti, G Lozano, A Pontecorvi, F Moretti, MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response. Oncogene. ,vol. 35, pp. 228- 240 ,(2016) , 10.1038/ONC.2015.76